Levels of estrogen receptors α and β in frontal cortex of patients with Alzheimer's disease: Relationship to mini-mental state examination scores

Current Alzheimer Research

Volumn 5, Issue 1, 2008, Pages 45-51

  Kelly, Jeremiah F ^a   Bienias, Julia L ^b   Shah, Avni ^a   Meeke, Kathleen A ^a   Schneider, Julie A ^a   Soriano, Edwin ^a   Bennett, David A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cognition; Dementia; Isoforms; Neuroprotection; Postmortem brain tissue; Splice variants

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN LEVEL; BRAIN TISSUE; COGNITIVE DEFECT; CONTROLLED STUDY; EDUCATION; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; MALE; MINI MENTAL STATE EXAMINATION; MULTIPLE LINEAR REGRESSION ANALYSIS; NEUROCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEOMICS; SEX DIFFERENCE; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; FRONTAL LOBE; HUMANS; MALE; PROTEIN ISOFORMS; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REFERENCE VALUES; SUBCELLULAR FRACTIONS;

EID: 42149127057     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720508783884611     Document Type: Article

References (44)

1. Chang D, Kwan J. and Timiras PS. Estrogens influence growth maturation and amyloid beta-peptide production in neuroblastoma cells and in a beta-APP transfected kidney 293 cell line. Adv Exp Med Biol 429: 261-271 (1997).
2. Manthey D, Heck S, Engert S. and Behl C. Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway. Eur J Biochem 268: 4285-4291 (2001).
3. Guerra B, Diaz M, Alonso R. and Marin R. Plasma membrane oestrogen receptor mediates neuroprotection against beta-amyloid toxicity through activation of Raf-1/MEK/ERK cascade in septal-derived cholinergic SN56 cells. J Neurochem 91: 99-109 (2004).
4. Fitzpatrick JL, Mize AL, Wade CB, Harris JA, Shapiro RA. and Dorsa DM. Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. J Neurochem 82: 674-682 (2002).
5. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon P. and Mendelsohn ME. Estrogen Receptor-alpha Mediates the Protective Effects of Estrogen Against Vascular Injury. Circ Res 90: 1087-1092 (2002).
6. Carswell HV, Macrae, IM, Gallagher L, Harrop E. and Horsburgh KJ. Neuroprotection by a selective estrogen receptor beta agonist in a mouse model of global ischemia. Am J Physiol Heart Circ Physiol 287: H1501-H1504 (2004).
7. Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A, Meda C, Krust A. Dupont S. Ciana P. Chambon P. and Maggi A. Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci USA 100: 9614-9619 (2003).
8. Baker AE, Brautigam VM. and Watters JJ. Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor beta. Endocrinology 145: 5021-5032 (2004).
9. Mize AL, Shapiro RA. and Dorsa DM. Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway. Endocrinology 144: 306-312 (2003).
10. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ. and Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51: 535-541 (1997).
11. Sato K. Matsuki N. Ohno Y. and Nakazawa K. Estrogens inhibit l-glutamate uptake activity of astrocytes via membrane estrogen receptor alpha. J Neurochem 86: 1498-1505 (2003).
12. Weaver C. E. Jr. Park-Chung M. Gibbs T. T. and Farb D. H. 17beta-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res 761: 338-341 (1997).
13. Ishunina TA. and Swaab DF. Increased expression of estrogen receptor alpha and beta in the nucleus basalis of Meynert in Alzheimer's disease. Neurobiol Aging 22: 417-426 (2001).
14. Ishunina TA, Wouda J, Fisser B. and Swaab DF. Sex differences in estrogen receptor alpha and beta expression in vasopressin neurons of the supraoptic nucleus in elderly and Alzheimer's disease patients: no relationship with cytoskeletal alterations. Brain Res 951: 322-329 (2002).
15. Ishunina TA, van Heerikhuize JJ, Ravid R. and Swaab DF. Estrogen receptors and metabolic activity in the human tuberomamillary nucleus: changes in relation to sex aging and Alzheimer's disease. Brain Res 988: 84-96 (2003).
16. Ishunina TA. and Swaab DF. Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of Broca in Alzheimer's disease: relation to sex and aging. Exp Neurol 183: 159-172 (2003).
17. Hu XY, Qin S, Lu YP, Ravid R, Swaab DF. and Zhou JN. Decreased estrogen receptor-alpha expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients. Acta Neuropathol (Berl) 106: 213-220 (2003).
18. Lu YP, Zeng M, Swaab DF, Ravid R. and Zhou JN. Colocalization and alteration of estrogen receptor-alpha and -beta in the hippocampus in Alzheimer's disease. Hum Pathol 35: 275-280 (2004).
19. Savaskan E, Olivieri G, Meier F, Ravid R. and Muller-Spahn F. Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer's disease. Brain Res 908: 113-119 (2001).
20. Ishunina TA, Kamphorst W. and Swaab DF. Changes in metabolic activity and estrogen receptors in the human medial mamillary nucleus: relation to sex aging and Alzheimer's disease. Neurobiol Aging 24: 817-828 (2003).
21. Shughrue PJ, Lane MV. and Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 388: 507-525 (1997).
22. Kritzer MF. Regional laminar and cellular distribution of immunoreactivity for ER alpha and ER beta in the cerebral cortex of hormonally intact adult male and female rats. Cereb Cortex 12: 116-128 (2002).
23. Kruijver FP, Balesar R, Espila AM, Unmehopa UA. and Swaab DF. Estrogen-receptor-beta distribution in the human hypothalamus: similarities and differences with ER alpha distribution. J Comp Neurol 466: 251-277 (2003).
24. Lindberg MK, Moverare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA. and Ohlsson C. Estrogen Receptor ER-beta Reduces ER-alpha-Regulated Gene Transcription Supporting a "Ying Yang" Relationship between ER-alpha and ER-beta in Mice. Mol Endocrinol 17: 203-208 (2003).
25. Beyer C, Pawlak J. and Karolczak M. Membrane receptors for oestrogen in the brain. J Neurochem 87: 545-550 (2003).
26. McKhann G, Drachman D, Folstein M, Katzman R, Price D. and Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944 (1984).
27. Wilson RS, Gilley DW, Bennett DA, Beckett LA. and Evans DA. Person-specific paths of cognitive decline in Alzheimer's disease and their relation to age. Psychol Aging 15: 18-28 (2000).
28. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G. and Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486 (1991).
29. Bennett DA, Cochran EJ, Saper CB, Leverenz JB, Gilley DW. and Wilson RS. Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease. Neurobiol Aging 14: 589-596 (1993).
30. Folstein MF, Folstein SE. and McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198 (1975).
31. Harrison PJ, Heath PR, Eastwood SL, Burnet PW, McDonald B. and Pearson RC. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 200: 151-154 (1995).
32. Herynk MH. and Fuqua SAW. Estrogen Receptor Mutations in Human Disease. Endocr Rev 25: 869-898 (2004).
33. Bennett DA, Schneider JA, Bienias JL, Evans DA. and Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 64: 834-841 (2005).
34. Lu YP, Zeng M, Swaab DF, Ravid R. and Zhou JN. Colocalization and alteration of estrogen receptor-alpha and -beta in the hippocampus in Alzheimer's disease. Hum Pathol 35: 275-280 (2004).
35. Toran-Allerand C. D. Minireview: A plethora of estrogen receptors in the brain: where will it end? Endocrinology 145: 1069-1074 (2004).
36. Flouriot G, Griffin C, Kenealy M, Sonntag-Buck V. and Gannon F. Differentially Expressed Messenger RNA Isoforms of the Human Estrogen Receptor-{alpha} Gene Are Generated by Alternative Splicing and Promoter Usage. Mol Endocrinol 12: 1939-1954 (1998).
37. Hirata S, Shoda T, Kato J. and Hoshi K. Isoform/variant mRNAs for sex steroid hormone receptors in humans. Trends Endocrinol Metab 14: 124-129 (2003).
38. Petersen DN. Tkalcevic GT, Koza-Taylor PH, Turi TG. and Brown TA. Identification of Estrogen Receptor beta 2 A Functional Variant of Estrogen Receptor {beta} Expressed in Normal Rat Tissues. Endocrinology 139: 1082-1092 (1998).
39. Saunders PT, Millar MR, Macpherson S, Irvine DS, Groome NP, Evans LR, Sharpe RM. and Scobie GA. ERbeta1 and the ERbeta2 splice variant (ERbetacx/beta2) are expressed in distinct cell populations in the adult human testis. J Clin Endocrinol Metab 87: 2706-2715 (2002).
40. Osterlund MK, Gustafsson JA, Keller E. and Hurd YL. Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERalpha mRNA. J Clin Endocrinol Metab 85: 3840-3846 (2000).
41. Osterlund MK, Keller E. and Hurd YL. The human forebrain has discrete estrogen receptor [alpha] messenger RNA expression: high levels in the amygdaloid complex. Neuroscience 95: 333-342 (1999).
42. Perlman WR, Matsumoto M, Beltaifa S, Hyde TM, Saunders RC, Webster MJ, Rubinow DR, Kleinman JE. and Weickert CS. Expression of estrogen receptor alpha exon-deleted mRNA variants in the human and non-human primate frontal cortex. Neuroscience 134: 81-95 (2005).
43. Ishunina TA, Swaab DF. and Fischer DF. Estrogen receptor-alpha splice variants in the medial mamillary nucleus of Alzheimer's disease patients: identification of a novel MB1 isoform. J Clin Endocrinol Metab 90: 3757-65 (2005).
44. Ishunina TA, Fischer DF. and Swaab DF. Estrogen receptor α and its splice variants in the hippocampus in aging and Alzheimer's diseasae. doi: 1016/jneurobiolaging.2006.07.024